Rubin SC, Hoskins WJ, Hakes TB, et al. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors. Am J Obstet Gynecol 1988;159:1094–1098.
242.
Berek JS, Griffith CT, Leventhal JM. Laparoscopy for second-look evaluation in ovarian cancer. Obstet Gynecol 1981;58:192– 198.
243.
Berek JS, Hacker NF. Laparoscopy in the management of patients with ovarian carcinoma. In: DiSaia P, ed. The treatment of ovarian cancer. Philadelphia, PA: WB Saunders, 1983:213–222.
244.
Lele S, Piver MS. Interval laparoscopy prior to second-look laparotomy in ovarian cancer. Obstet Gynecol 1986;68:345– 347.
245.
Berek JS, Knapp RC, Malkasian GD, et al. CA125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol 1986;67:685–689.
246.
Lavin PT, Knapp RC, Malkasian GD, et al. CA125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol 1987;69:223–227.
247.
Rustin GJ, Bast RC, Kelloff GJ, et al. Use of CA125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res 2004;10:3919–3926.
248.
De Rosa V, Mangioni di Stefano ML, et al. Computed tomography and second-look surgery in ovarian cancer patients: correlation, actual role and limitations of CT scan. Eur J Gynaecol Oncol 1995;16:123–129.
249.
Lund B, Jacobson K, Rasch L, et al. Correlation of abdominal ultrasound and computed tomography scans with second-or third-look laparotomy in patients with ovarian carcinoma. Gynecol Oncol 1990;37:279–283.
250.
Berek JS, Hacker NF, Lagasse LD, et al. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983;61:189–193.
251.
Hoskins WJ, Rubin SC, Dulaney E, et al. Inﬂuence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 1989;34: 365–371.
252.
Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction in advanced epithelial ovarian cancer: patient selection and review of the literature. Cancer 1996;78:2049–2062.
253.
Berek JS, Trop´e C, Vergote I. Surgery during chemotherapy and at relapse of ovarian cancer. Ann Oncol 1999;10:S3–7.
254.
Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144–153.
255.